6 completed, 2 terminated, 1 recruiting. 9 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 6, Terminated 2, Recruiting 1 |
| Phase 2 | 3 | Completed 3 |
Follow Supranuclear Palsy, Progressive: new trials by email Literature Review of Supranuclear Palsy, Progressive trials Research Report on Supranuclear Palsy, Progressive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy NIO752, Placebo - Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS) | Phase 3 | Recruiting | Novartis Pharmaceuticals | 300 | 2026-06-03 | 2026-10-15 |
| AMX0035 and Progressive Supranuclear Palsy AMX0035, Placebo - Progressive Supranuclear Palsy, PSP | Phase 2 / Phase 3 | Completed | Amylyx Pharmaceuticals Inc. | 139 | 2023-12-21 | 2026-04-30 |
| A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients DaTSCAN™ Ioflupane (123I) Injection - Parkinsonian Syndrome, Parkinson Disease(PD) | Phase 3 | Completed | GE Healthcare | 172 | 2020-06-28 | 2023-10-16 |
| Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis Placebo, Pimavanserin 34 mg, Pimavanserin 20 mg - Dementia-related Psychosis | Phase 3 | Completed | ACADIA Pharmaceuticals Inc. | 392 | 2017-09-27 | 2021-06-21 |
| Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy Rivastigmine, Placebo - Progressive Supranuclear Palsy (PSP) | Phase 3 | Completed | Assistance Publique Hopitaux De Marseille | 106 | 2016-07-26 | 2023-07-20 |
| Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy Davunetide, Placebo - Progressive Supranuclear Palsy | Phase 2 / Phase 3 | Completed | Allon Therapeutics | 313 | 2010-10-01 | 2013-01-17 |
| Efficacy, Tolerability and Safety of Azilect in Subjects With Progressive Supranuclear Palsy Rasagiline, Sugar pill - Progressive Supranuclear Palsy | Phase 3 | Terminated | Prof. Dr. Stefan Lorenzl | 44 | 2010-01-01 | 2013-04-24 |
| Effects of Coenzyme Q10 in PSP and CBD CoQ10 - Progressive Supranuclear Palsy, Neurological Disorders | Phase 2 / Phase 3 | Completed | Lahey Clinic | 2004-01-01 | 2018-06-15 | |
| Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS) Riluzole - Multiple System Atrophy, Progressive Supranuclear Palsy | Phase 3 | Terminated | King's College London | 800 | 2000-04-01 | 2005-12-15 |
Multiple System Atrophy (2) · Alzheimer Disease (1) · Corticobasal Degeneration (1) · Delusions (1) · Dementia (1) · Dementia, Vascular (1) · Essential Tremor (1) · Hallucinations (1) · Lewy Body Disease (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Parkinson Disease (1) · Parkinsonian Disorders (1) · Pick Disease of the Brain (1)
Basal Ganglia Diseases (9) · Brain Diseases (9) · Central Nervous System Diseases (9) · Cranial Nerve Diseases (9) · Eye Diseases (9) · Movement Disorders (9) · Neurologic Manifestations (9) · Ocular Motility Disorders (9) · Ophthalmoplegia (9) · Paralysis (9) · Pathological Conditions, Signs and Symptoms (9) · Signs and Symptoms (9) · Tauopathies (9) · Nervous System Diseases (8) · Neurodegenerative Diseases (8)
Injections (1) · Iodine-123 (1) · Riluzole (1) · Rivastigmine (1) · Sugars (1) · coenzyme Q10 (1) · davunetide (1) · ioflupane (1) · pimavanserin (1) · rasagiline (1) · sodium phenylbutyrate and taurursodiol (1)
ACADIA Pharmaceuticals Inc. (1) · Allon Therapeutics (1) · Amylyx Pharmaceuticals Inc. (1) · Assistance Publique Hopitaux De Marseille (1) · GE Healthcare (1) · King's College London (1) · Lahey Clinic (1) · Novartis Pharmaceuticals (1) · Prof. Dr. Stefan Lorenzl (1)
France (5) · Germany (5) · United States (5) · United Kingdom (4) · Italy (3) · Spain (3) · Australia (2) · China (2) · Belgium (1) · Bulgaria (1) · Canada (1) · Chile (1) · Czechia (1) · Japan (1) · Netherlands (1)
Adam Boxer, M.D., PhD. (1) · Diana Apetauerova, MD (1) · Peter N Leigh, PhD FRCP (1) · Stefan Lorenzl, PD Dr. (1)
PMID 19029129, PMID 19771175, PMID 21386111, PMID 21829612, PMID 24873720, PMID 28436538, PMID 34289275, PMID 34934801, PMID 38825840, PMID 41286676
2008 (1), 2016 (1), 2017 (1)